Harvard Health Columns

Lowering Drug Costs after Canada Dries Up

The Canadian Minister of Health recently voiced his concern about the American impact on the Canadian prescription drug supply. It is very likely that the availability of less expensive Canadian drugs for Americans is coming to an end. The Canadian government's approach to prescription drug pricing is not like the American approach. The Canadian government negotiates price contracts with mostly U.S.-based pharmaceutical companies. As a result, Canadians pay considerably less than their U.S.…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In